Now is the time to solve the industry’s identity crisis, and it can only be done through a combination of phishing-resistant and adaptive MFA, fine-grained access control, and standards-based interoperability.
While other areas of healthcare have been star-struck by sophisticated AI and massive infrastructure investments, safety net entities have found that the answer is much simpler. Better managing chronic conditions across populations simply requires the right connection at the right time.
Since its inception, AI in prior auth has only been at work in the commercial healthcare marketplace. Now new innovative approaches that reframe prior auth as a resource instead of a roadblock have come to Medicare via the WISeR model.
The question is no longer whether shareback matters. It is whether the healthcare ecosystem is willing to prioritize it in practice by recognizing it in policy measurement, monitoring, and enforcement, as well as investing in the technical and governance structures needed to make shareback routine, high-quality, measurable, and reportable.
Healthcare interoperability isn’t an abstract concept; it’s about human connection, building trust and easing burden on patients and their care providers.
By using AI-powered intelligence to shift clinical and coding validation earlier in the healthcare continuum, and unlocking upstream clinical data to inform downstream payment workflows, organizations can proactively prevent errors, reduce downstream churn and friction, and support more predictable, accurate, and timely payments.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Care delivery doesn’t have to be binary — in-person or virtual, old model or new. It can be adaptive, team-based, and deeply human.
The challenge isn’t whether AI can be used (it already is). It’s whether it can be trusted. And trust in medicine is not something healthcare professionals can afford to get wrong.
The difference between that last era and this one isn’t incremental. It’s categorical. Artificial intelligence isn’t optimizing the old system. It’s making the old system economically indefensible.
These products have yet to offer treatment solutions designed to get users from their current health state to a desired future health state. This creates a massive, untapped opening for tools that move people from awareness to action in a clinically meaningful way, without the cost and access barriers of engaging the healthcare system or requiring a prescription.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
The next wave of radiology AI value will come from closed-loop follow-up. An actionable finding should start a pathway with a measurable end state: the follow-up exam is completed, the referral is completed, or the recommendation is clinically resolved with a documented rationale.
To address the clinical burden and enhance R&D, companies are turning to virtual solutions. This involves synthetic data, digital twin models, and AI to speed analysis.
The question is where will healthcare see the greatest value? Here are five use cases that define the greatest ROI for leveraging agentic AI for clinical supply chain operations.
While many AI conversations revolve around regulated industry transformation, the question is where to actually start in a way that does not break trust, budgets or regulatory limits.
The patient's voice should be an entry point and not a barrier to better compliance and health outcomes. A nurse practitioner outlines a protocol for a frank exam-room exchange that sustains cultural humility.